Document is current
Any future updates will be listed below
-
Authors
Cardozo, T
Shmelkov, E
Felsovalyi, K
Swetnam, J
Butler, T
Malaspina, D
Shmelkov, S V
- License Information
-
More Information
Article History
Received: 20 September 2016
Revised: 6 December 2016
Accepted: 29 December 2016
First Online: 21 February 2017
Competing interests
: TC is a named inventor on a patent (‘Method of Identifying the molecular basis of the activity of a drug compound, pharmaceutical compositions, and treatment methods.’ US Patent Application #14/538,950). TC is a founder and a shareholder of GeneCentrix. This work was supported by NIH grant RC LM010994 from the National Library of Medicine to TC. ES is a named inventor on a patent (‘Method of Identifying the molecular basis of the activity of a drug compound, pharmaceutical compositions, and treatment methods.’ US Patent Application #14/538,950). SVS is a founder and a shareholder of GeneCentrix. No funding was received from GeneCentrix for the present study. The remaining authors declare no conflict of interest.
